Sodium-Glucose Cotransporter 2 Inhibitors and Kidney Outcomes across the Spectrum of Kidney Disease: A Systematic Review and Meta-Analysis

医学 肾 荟萃分析 重症监护医学 肾脏疾病 内科学 梅德林 生物信息学 泌尿科 政治学 生物 法学
作者
Bernardo Frison Spiazzi,Giovana Fagundes Piccoli,Laura Fink Wayerbacher,João Pedro Neves Lubianca,Bruno G. Scalco,Mariana Hollmann Scheffler,Bruna L. Fraga,Verônica Colpani,Fernando Gerchman
出处
期刊:Clinical Journal of The American Society of Nephrology [Lippincott Williams & Wilkins]
卷期号:20 (1): 39-49 被引量:20
标识
DOI:10.2215/cjn.0000000000000568
摘要

Key Points The effect of sodium-glucose cotransporter 2 inhibitors in preventing kidney outcomes in populations at lower risk of kidney disease remains uncertain. Pooled data from randomized controlled trials show that sodium-glucose cotransporter 2 inhibitors prevent kidney outcomes across the spectrum of kidney disease risk. Background Sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown to reduce clinically meaningful kidney outcomes in individuals with CKD at high risk of adverse outcomes. The effect of these agents in preventing clinically meaningful kidney outcomes in populations at lower risk remains uncertain. We aim to evaluate the effect of SGLT2 inhibitors on kidney outcomes across the Kidney Disease Improving Global Outcomes (KDIGO) classification and urinary albumin-creatinine ratio (UACR) levels. Methods We have searched medical literature analysis and retrieval system online (PubMed), excerpta medica database, and Cochrane Central Register of Controlled Trials from inception up to August 8, 2023. In pairs, researchers selected large (≥500 participants per arm) randomized placebo-controlled trials of SGLT2 inhibitors, with a minimum duration of 1 year. Researchers independently extracted study-level data and assessed within-study risk of bias with the risk of bias 2.0 tool and quality of evidence with grading of recommendations, assessment, development and evaluation. Results We included ten trials, encompassing 78,184 participants and a median follow-up of 2.7 years. Risk of bias was overall low. We performed meta-analyses summarizing individual study hazard ratios (HRs) and 95% confidence intervals (CIs) using a random-effects model. SGLT2 inhibitors reduced the composite kidney outcome across all KDIGO (HR [95% CI]: low 0.48 [0.32 to 0.71], moderate 0.60 [0.39 to 0.93], high 0.59 [0.47 to 0.74], very high 0.59 [0.49 to 0.72]) and UACR (HR [95% CI]: <30 mg/g 0.62 [0.50 to 0.78], ≥30 to ≤300 mg/g 0.80 [0.67 to 0.96], >300 mg/g 0.61 [0.52 to 0.73]) groups, without evidence of heterogeneity between groups. A small proportion of participants without diabetes in low-risk groups were referred, and there was lack of standardization of composite outcomes. Conclusions SGLT2 inhibitors consistently reduce kidney outcomes across the spectrum of KDIGO classes and UACR levels. Clinical Trial registry name and registration number: CRD42023492877.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
甜美的含之完成签到,获得积分10
1秒前
怎么办完成签到,获得积分10
1秒前
1秒前
SciGPT的应助被胡萝卜卜采纳,获得10
1秒前
莫断痕发布了新的文献求助10
1秒前
夏旸发布了新的文献求助30
2秒前
小兔兔猎魊完成签到,获得积分10
3秒前
秋风的应助被17采纳,获得10
3秒前
十六完成签到,获得积分20
3秒前
医嘱摸鱼专员完成签到,获得积分10
3秒前
3秒前
科研通AI6.3的应助被洁净山柏采纳,获得10
3秒前
YouHan发布了新的文献求助10
5秒前
5秒前
微信研友发布了新的文献求助10
5秒前
Matt完成签到,获得积分10
6秒前
6秒前
7秒前
Seraphim完成签到,获得积分10
7秒前
ColinWine完成签到,获得积分0
8秒前
8秒前
9秒前
Zex发布了新的文献求助20
10秒前
fantasy的应助被Parker采纳,获得10
10秒前
10秒前
12秒前
莫断痕发布了新的文献求助10
12秒前
12秒前
尊敬的灰狼完成签到 ,获得积分10
13秒前
13秒前
13秒前
14秒前
fghgg发布了新的文献求助30
14秒前
HQ发布了新的文献求助10
14秒前
杨媛发布了新的文献求助20
15秒前
平贝花发布了新的文献求助10
15秒前
华仔的应助被儒雅从安采纳,获得10
15秒前
15秒前
格物致知完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194174
求助须知:如何正确求助?哪些是违规求助? 9580103
关于积分的说明 21869209
捐赠科研通 7793764
什么是DOI,文献DOI怎么找? 3437545
关于科研通互助平台的介绍 2560983
邀请新用户注册赠送积分活动 2484291